NKTX Message Board Post 10001942 | Nkarta Inc.
home / stock / nktx / nktx message board
stellasharon
(investorshub)
Posted on: Apr/01/2023 20:35:01
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171596214
Updated results from the ongoing trial of NKX101
News, Short Squeeze, Breakout and More Instantly...
-
SOUTH SAN FRANCISCO, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced changes to its leadership team. Nadir Mahmood, Ph.D., will join Nkarta as President this month, sharing...
-
Patient screening underway in Ntrust-1, the first U.S.-based clinical trial of an engineered NK cell therapy for the treatment of lupus nephritis IND cleared for Ntrust-2, a clinical trial for NKX019 for the treatment of systemic sclerosis, myositis and vasculitis Clinical data ...